Gilead Sciences (GILD) PT Raised to $175 at Morgan Stanley

April 10, 2026 8:15 AM

Morgan Stanley analyst Terence Flynn raised the price target on Gilead Sciences (NASDAQ: GILD) to $175.00 (from $171.00) while maintaining a Overweight rating.

No results found